ADLM 2026 Clinical Lab Expo
This July, the Binding Site team will join leading innovators, researchers, and clinicians from around the world at ADLM 2026 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo).
As the largest global event dedicated to laboratory medicine, ADLM brings together experts across clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, and laboratory management. In partnership with the Canadian Society for Clinical Chemistry (CSCC), the 2026 program will offer a dynamic forum for discovery, education, and collaboration.
About us
At the Binding Site, part of Thermo Fisher Scientific, we are committed to advancing the science and practice of protein diagnostics. Our suite of assays and analyzers have been developed through scientific leadership and an unwavering focus on patient impact, helping laboratories deliver earlier, more accurate, and actionable insights across multiple myeloma, immune status disorders and other specialized conditions.
We invite you to visit the Thermo Fisher Scientific booth to
- Explore our latest solutions for protein diagnostics, including the market-leading Freelite™ assay, our Optilite™ special protein analyzer, and the EXENT™ System
- Learn how we are addressing emerging clinical needs through innovation and collaboration
- Engage with our experts on the evolving role of protein testing in advancing patient care
- Connect with fellow laboratory professionals shaping the future of diagnostics
†coming soon
Discover Binding Site’s solution for special protein testing
What to see at our booth:
Optilite Analyser
Assay menu
EXENT System*
Software solutions
†coming soon
Attend our micro lectures on July 28 and 29 at booth #3501
The EXENT™ System: Delivering clearer insights in Multiple Myeloma
Date and time: Tuesday, July 28, 10:00 AM (PT)
Comparison of human immunoglobulins and free light chain testing workflow and efficiency on the Optilite standalone analyzer and an integrated chemistry analyzer with automation
Date and time: Wednesday, July 29, 11:30 AM (PT)
Industry workshop
Next-level diagnostics with the EXENT™ System:
Built for the lab. Designed for the clinic. Focused on the patient.
Wednesday, July 29 | 10:15 – 11:15 AM (PT) | Theater 1, ADLM Exhibition Hall
Overview
This session examines current monoclonal gammopathy assessment practices and challenges, with a practical focus on M-protein measurement in blood and its impact on analytical confidence and clinical decision-making. From speakers with real world laboratory experience, attendees will discover how the EXENT system applies mass spectrometry in a purpose-built, automated solution - streamlining workflows, and enabling the lab to deliver clearer answers for clinicians and patients alike.
Outcome
1. Review laboratory practices for monoclonal gammopathy assessment including the current challenges and opportunities
2. Learn about M-protein measurement in the blood and how this impacts laboratory and clinical decisions
3. Understand how mass spectrometry impacts the future of monoclonal gammopathy assessment
Moderator:
Speakers:
Jill Pauli, PhD
Associate Director, Scientific Affairs | Binding Site, part of Thermo Fisher Scientific
Steven E. Conklin-López, PhD, NRCC
Shelby Hutcherson, PhD, DABCC
Whether you are looking to optimize your current protein testing workflows or stay ahead of the latest developments in laboratory science, we welcome the opportunity to meet with you at ADLM 2026!
*The EXENT™ System combines EXENT™ Analyser with the Immunoglobulin Isotypes (GAM) for the EXENT™ Analyser.
© 2026 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific or its subsidiaries.
Product availability is subject to country specific regulatory requirements.
Contact your local representative for availability in your country.
†This product is not commercially available in the USA and commercial availability cannot be guaranteed. Performance characteristics have not been established.